Her deadly diagnosis only had 1 warning sign. Here's how she survived.
Summary
Becca Valle was diagnosed with glioblastoma, a deadly brain tumor, after experiencing severe headaches. She joined a clinical trial that used focused ultrasound to temporarily open the blood-brain barrier, allowing chemotherapy to reach her brain more effectively, which showed promising early results.Key Facts
- Becca Valle had persistent headaches and vomiting before being diagnosed with glioblastoma in 2021.
- Glioblastoma is a type of brain cancer that is hard to treat because the blood-brain barrier blocks most drugs.
- Valle underwent surgery to remove her tumor, followed by chemotherapy and radiation.
- She joined a clinical trial testing focused ultrasound to open the blood-brain barrier briefly.
- The ultrasound works by using sound waves to activate microbubbles that loosen blood vessels in the brain.
- Opening the barrier lets chemotherapy drugs enter the brain more easily for a few hours.
- The trial included 34 patients, each having 3 to 6 ultrasound treatments over six months.
- Early results showed about 40% of patients survived longer than expected with this treatment.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
